I'm sure our friends across the pond will be thrilled about this.
Looking up "weight loss drug prices UK" I found this:
"Mounjaro prices will jump by 170% in the UK, says its maker, as some politician puts pressure on companies to hike prices for Europeans to make them cheaper for Americans. Aug 14 2025
https://www.theguardian.com › business ›"
Luckily for me here in Aus, we have a pretty good system for controlling drug prices. Most scripts are capped at around $40, or $8 for pensioners. Ozempic is subsidized for diabetics only; cost me about $140 aud a month for 1mg/week if I wasn't diabetic. Tirzepatide is $690 a month for 15mg/week! It'd need to be way lower to be subsidized here. Ozempic made me feel sick, anyway.
Too bad for Americans without deep pockets. Drug prices there are among the highest. Helps fund research, I guess. But many die early because they can't afford preventative meds.
One report says generic ozempic will be like $50/month in the US by 2030. And once Chinese-researched drugs get approved in the US, competition should drive prices down further, maybe by 2027/28. Plus, tons of anti-obesity drugs are in development, many GLP-1 types. Hopefully, a dozen or more will eventually compete, pushing prices lower and effectiveness higher.